Literature DB >> 26823806

Matrine inhibited proliferation and increased apoptosis in human breast cancer MCF-7 cells via upregulation of Bax and downregulation of Bcl-2.

Haijun Li1, Xiujuan Li1, Meiling Bai1, Yueer Suo2, Guohui Zhang1, Xueyuan Cao2.   

Abstract

PURPOSE: The aim of the present study was to investigate the effects of matrine on proliferation and apoptosis in human breast cancer MCF-7 cells and its relevant molecular mechanisms.
METHODS: Breast carcinoma cell line MCF-7 was cultured with series concentrations of Matrine in vitro. The proliferation and apoptosis of MCF-7 cells were investigated by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay, flow cytometry, and Mitochondrial membrane potential (MMP) measurements. The expression levels of Bax and Bcl-2 proteins were detected by Annexin V/propidium iodide coupled staining. The morphological changes of MCF-7 cell were examined.
RESULTS: The inhibition rates of MCF-7 cells were 6.01%-37.01%, 7.56%-53.92%, and 10.86%-70.23% for 24, 48, and 72 hours after Matrine treatment, respectively. The proliferation of MCF-7 cells was significantly inhibited by Matrine administration, with a time and dose dependent manner. The rates apoptotic cells was between 4.17±0.25% and 19.63±0.17% in 0.25-2.0 mg/ml Matrine groups, which had significant increased compare with the control groups (1.10±0.08%, P<0.05). Meanwhile, increased Bax expression, but decreased Bcl-2 expression was observed in MCF-7 cell line. MMP were significantly decreased by Matrine treatment.
CONCLUSIONS: Matrine significantly inhibited the growth and induced apoptosis in breast carcinoma MCF-7 cells, which is related to Bax, Bcl-2 signaling and MMP.

Entities:  

Keywords:  Bax; Bcl-2; Matrine; apoptosis; breast cancer; mitochondrial; proliferation

Mesh:

Substances:

Year:  2015        PMID: 26823806      PMCID: PMC4713592     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  26 in total

Review 1.  Cancer chemoprevention with dietary phytochemicals.

Authors:  Young-Joon Surh
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

Review 2.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

Authors:  Peter E Czabotar; Guillaume Lessene; Andreas Strasser; Jerry M Adams
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01       Impact factor: 94.444

3.  Matrine induces mitochondrial apoptosis in cisplatin-resistant non-small cell lung cancer cells via suppression of β-catenin/survivin signaling.

Authors:  Huan-Qin Wang; Jian-Jun Jin; Jing Wang
Journal:  Oncol Rep       Date:  2015-03-09       Impact factor: 3.906

4.  Matrine upregulates the cell cycle protein E2F-1 and triggers apoptosis via the mitochondrial pathway in K562 cells.

Authors:  Hua Jiang; ChunHui Hou; ShuBing Zhang; HengYue Xie; WeiYing Zhou; QiHuang Jin; XiaoDong Cheng; RuoLan Qian; XueJun Zhang
Journal:  Eur J Pharmacol       Date:  2007-01-17       Impact factor: 4.432

5.  Induced differentiation of hepatocellular carcinoma by natural products.

Authors:  Xiong-Zhi Wu; Guang-Ru Xie
Journal:  Afr J Tradit Complement Altern Med       Date:  2008-06-18

Review 6.  Overview of resistance to systemic therapy in patients with breast cancer.

Authors:  Ana Maria Gonzalez-Angulo; Flavia Morales-Vasquez; Gabriel N Hortobagyi
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

Review 7.  Anti-tumor activities of matrine and oxymatrine: literature review.

Authors:  Yan Liu; Yang Xu; Weidan Ji; Xiaoya Li; Bin Sun; Quangen Gao; Changqing Su
Journal:  Tumour Biol       Date:  2014-02-14

8.  FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway.

Authors:  Abedul Haque; Mohammad A Rahman; James R Fuchs; Zhuo Georgia Chen; Fadlo R Khuri; Dong M Shin; A R M Ruhul Amin
Journal:  Cancer Lett       Date:  2015-04-24       Impact factor: 8.679

9.  Matrine inhibits invasiveness and metastasis of human malignant melanoma cell line A375 in vitro.

Authors:  Xiao-Yan Liu; Hong Fang; Zheng-Gang Yang; Xiao-Yong Wang; Li-Ming Ruan; De-Ren Fang; Ying-Guo Ding; Yi-Na Wang; Yu Zhang; Xiao-Ling Jiang; Hong-Chao Chen
Journal:  Int J Dermatol       Date:  2008-05       Impact factor: 2.736

10.  4-Vinyl-2,6-dimethoxyphenol (canolol) suppresses oxidative stress and gastric carcinogenesis in Helicobacter pylori-infected carcinogen-treated Mongolian gerbils.

Authors:  Xueyuan Cao; Tetsuya Tsukamoto; Takahiro Seki; Harunari Tanaka; Shigeru Morimura; Liyu Cao; Tsutomu Mizoshita; Hisayo Ban; Takeshi Toyoda; Hiroshi Maeda; Masae Tatematsu
Journal:  Int J Cancer       Date:  2008-04-01       Impact factor: 7.396

View more
  23 in total

1.  Neuroprotective effects of matrine on scopolamine-induced amnesia via inhibition of AChE/BuChE and oxidative stress.

Authors:  Kaiyue Sun; Yuting Bai; Rong Zhao; Zijiao Guo; Xiang Su; Peiqi Li; Pengyu Yang
Journal:  Metab Brain Dis       Date:  2018-11-07       Impact factor: 3.584

2.  Matrine inhibits cell proliferation and induces apoptosis of human rhabdomyosarcoma cells via downregulation of the extracellular signal-regulated kinase pathway.

Authors:  Penghui Yan; Zongqiang Huang; Junbo Zhu
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

Review 3.  Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-28       Impact factor: 15.470

4.  Effect of matrine combined with cisplatin on the expression of XIAP in human rhabdomyosarcoma RD cells.

Authors:  Li Li; Tianyang Xue; Wei Xu; Bin Zhou
Journal:  Oncol Lett       Date:  2016-09-19       Impact factor: 2.967

5.  Effect of matrine against breast cancer by downregulating the vascular endothelial growth factor via the Wnt/β-catenin pathway.

Authors:  Xu Xiao; Man Ao; Fan Xu; Xiao Li; Jiuli Hu; Ying Wang; Daixiao Li; Xiaoqin Zhu; Chunlan Xin; Wenda Shi
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

6.  Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathway.

Authors:  Xiao-Zhong Liao; Lan-Ting Tao; Jia-Hui Liu; Yue-Yu Gu; Jun Xie; Yuling Chen; Mei-Gui Lin; Tao-Li Liu; Dong-Mei Wang; Hai-Yan Guo; Sui-Lin Mo
Journal:  Cancer Cell Int       Date:  2017-12-28       Impact factor: 5.722

7.  Matrine suppresses the migration and invasion of NSCLC cells by inhibiting PAX2-induced epithelial-mesenchymal transition.

Authors:  Jun Yang; Du He; Yan Peng; Hongzhen Zhong; Yuhong Deng; Zhonghua Yu; Chengnong Guan; Yufang Zuo; Zumin Xu
Journal:  Onco Targets Ther       Date:  2017-10-27       Impact factor: 4.147

8.  LncRNA GASL1 inhibits growth and promotes expression of apoptosis-associated proteins in prostate carcinoma cells through GLUT-1.

Authors:  Zhiqin Li; Hong Liu; Wen Ju; Yifei Xing; Xiaoping Zhang; Jun Yang
Journal:  Oncol Lett       Date:  2019-04-12       Impact factor: 2.967

9.  Fractional Deletion of Compound Kushen Injection Indicates Cytokine Signaling Pathways are Critical for its Perturbation of the Cell Cycle.

Authors:  T N Aung; S Nourmohammadi; Z Qu; Y Harata-Lee; J Cui; H Y Shen; A J Yool; T Pukala; Hong Du; R D Kortschak; W Wei; D L Adelson
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

10.  Immunotherapy of Dual-Function Vector with Both Immunostimulatory and B-Cell Lymphoma 2 (Bcl-2)-Silencing Effects on Gastric Carcinoma.

Authors:  Lanying Ma; Mei Han; Zumureti Keyoumu; Hua Wang; Saifuding Keyoumu
Journal:  Med Sci Monit       Date:  2017-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.